Search research articles
Contact Us
Filters
Showing results (231-240 of 250) with videos related to
Page
of 25
Sort By:
Journal of Neurodevelopmental Disorders
|
December 5, 2021
Social visual attentional engagement and memory in Phelan-McDermid syndrome and autism spectrum disorder: a pilot eye tracking study
Sylvia B Guillory, Victoria Z Baskett, Hannah E Grosman, et al.
Cancer
|
December 21, 2021
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia
Kelsey-Leigh A Garcia, Sindhu Cherian, Philip A Stevenson, et al.
Leukemia & Lymphoma
|
September 14, 2020
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms
Anna B Halpern, Megan Othus, Nicholas P Howard, et al.
Leukemia
|
May 31, 2017
Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study
A B Halpern, M Othus, E M Huebner, et al.
Leukemia
|
December 12, 2022
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms
Carla S Walti, Anna B Halpern, Hu Xie, et al.
Ecological Applications : a Publication of the Ecological Society of America
|
October 28, 2016
A cross-continental comparison of plant and beetle responses to retention of forest patches during timber harvest
Susan C Baker, Charles B Halpern, Timothy J Wardlaw, et al.
JCO Oncology Practice
|
May 6, 2020
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy
Mary-Elizabeth M Percival, Ryan C Lynch, Anna B Halpern, et al.
Leukemia
|
May 4, 2018
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms
Anna B Halpern, Megan Othus, Emily M Huebner, et al.
European Journal of Haematology
|
September 6, 2023
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia
Lucas C Zarling, Philip A Stevenson, Lorinda A Soma, et al.
Transplantation and Cellular Therapy
|
May 6, 2024
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms
Noam E Kopmar, Megan Othus, Kim Quach, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 250) with videos related to
Sort By:
Page
of 25
Journal of Neurodevelopmental Disorders
|
December 5, 2021
Social visual attentional engagement and memory in Phelan-McDermid syndrome and autism spectrum disorder: a pilot eye tracking study
Sylvia B Guillory, Victoria Z Baskett, Hannah E Grosman, et al.
Cancer
|
December 21, 2021
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia
Kelsey-Leigh A Garcia, Sindhu Cherian, Philip A Stevenson, et al.
Leukemia & Lymphoma
|
September 14, 2020
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms
Anna B Halpern, Megan Othus, Nicholas P Howard, et al.
Leukemia
|
May 31, 2017
Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study
A B Halpern, M Othus, E M Huebner, et al.
Leukemia
|
December 12, 2022
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms
Carla S Walti, Anna B Halpern, Hu Xie, et al.
Ecological Applications : a Publication of the Ecological Society of America
|
October 28, 2016
A cross-continental comparison of plant and beetle responses to retention of forest patches during timber harvest
Susan C Baker, Charles B Halpern, Timothy J Wardlaw, et al.
JCO Oncology Practice
|
May 6, 2020
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy
Mary-Elizabeth M Percival, Ryan C Lynch, Anna B Halpern, et al.
Leukemia
|
May 4, 2018
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms
Anna B Halpern, Megan Othus, Emily M Huebner, et al.
European Journal of Haematology
|
September 6, 2023
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia
Lucas C Zarling, Philip A Stevenson, Lorinda A Soma, et al.
Transplantation and Cellular Therapy
|
May 6, 2024
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms
Noam E Kopmar, Megan Othus, Kim Quach, et al.
Page
of 25